Reports suggest that at the basis of AIH development is an interaction between specific genetic traits and molecular mimicry for disease development and impairment of immunoregulatory mechanisms between effector and regulatory immunity with the CD4+ population and Treg cells, alongside the contributory roles played by CD8+ cytotoxicity and autoantibody production by the B cells. Here, CD4 is linked to autoimmune hepatitis.